Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
RETINOL DERIVATIVES, THEIR USE IN THE TREATMENT OF CANCER AND FOR POTENTIATING THE EFFICACY OF OTHER CYTOTOXIC AGENTS

No-Receipt date 2013-02337 - 29/07/2013
No-Filing date 20130401560 - 29/07/2013
No-Granting date 3081291 - 31/07/2013
No-EPO application date 02783947.1 - 15/11/2002
No-EPO granting date 1534672 - 01/05/2013
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 7/2013 - 29/08/2013
Expiration date 16/11/2022
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities SE020231123/07/2002/SE
US398200 P23/07/2002/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07C 403/20

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
478553 ARDENIA INVESTMENTS LTD. FIRST FLOOR, 45 WELBECK STREETLONDON W1G 8DZ UNITED KINGDOM (GREAT BRITAIN)

Inventors
CodeFirstnameSurname
1143292 STRELCHENOK, OLEG
1143293 ALEKSOV, JULIAN

Representatives
CodeFirstnameSurnameAddressTownZip
2011VALI-VASILIKISAKELLARIDIADRIANOY 70ATHINA (ATTIKIS)10556

Contact
CodeFirstnameSurnameAddressTownZipCountry
5848VALI-VASILIKISAKELLARIDIADRIANOY 70ATHINA (ATTIKIS)10556 GREECE

Owners History

Title Instruments
DateOperationDescreption
6/5/2019 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 05/2019 - Αρ. Πρωτ. ΓΔ 1194 / 05-06-2019 (Κανονικά στο number έπρεπε να εισαχθεί 11949 αλλά λόγω του ότι προυπήρχε εισήχθη 1194 δηλαδή ο αριθμός πρωτοκόλλου χωρίς ένδειξη έτους)

Payments history 16 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015